Chronic analgesic study on buprenorphine action in cancer pain. Comparison with pentazocine.
Buprenorphine appears to have an analgesic effect (evaluated after a week of treatment) statistically superior to that of the comparative drug. On the whole, during buprenorphine treatment the normal activities of life of the individual patient improved. The percentage incidence of the side-effects is similar for the two drugs. Buprenorphine, however, caused less intense side-effects than pentazocine.
D000328:Adult; D000368:Aged; D002047:Buprenorphine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D009019:Morphinans / Q000627:therapeutic use*; D009369:Neoplasms / Q000150:complications*; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D010423:Pentazocine / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D009019:Morphinans; D002047:Buprenorphine; D010423:Pentazocine